Hepatitis Forums
Hepatitis C Main Forums => Post Hepatitis C Treatment => Topic started by: Hep Editors on February 03, 2020, 11:30:32 am
-
After people who inject drugs (PWID) are cured of hepatitis C virus (HCV), young men in particular have a higher rate of reinfection with the virus. Consistent use of medication-assisted treatment (MAT) for opioid use disorder, however, can apparently greatly mitigate the reinfection risk among PWID.
These are the findings of a Canadian study presented by Naveed Janjua, MBBS, of the British Columbia Centre for Disease Control at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases, in Boston this month.
Janjua and his colleagues analyzed data from the British Columbia Hepatitis Testers Cohort, which included some 1.3 million people screened for HCV in the province. The analysis focused on 5,702 people with HCV who were treated with direct-acting antivirals and who achieved a sustained virologic response 12 weeks after completing therapy (SVR12, considered a cure) and had at least one subsequent measurement of their HCV RNA through April 2019.
Read more...
https://www.hepmag.com/article/posthep-c-cure-young-men-inject-drugs-likely-get-virus